Atlas Trials

Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage and Associated Mood and Physiological Effects

Clinical trial NCT05096780 · COMPLETED

Trial details

NCT number
NCT05096780
Sponsor
PepsiCo Global R&D
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alertness
Start date
2021-10-08
Primary completion
2022-02-06
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.